cupcakes Lexaria Bioscience seeing increased demand for its DehydraTECH drug delivery system

DehydraTECH masks unwanted taste, improves onset speed and increases bioavailability of active...

3 days, 20 hours ago
Deep dive

Imugene progresses towards human studies for PD1-Vaxx treatment by the end...

The company is well-funded to deliver on commercial and clinical milestones including the...

5 days, 1 hour ago
Deep dive

AIM ImmunoTech is developing immuno-therapeutics to treat multiple types of...

A study has also shown that lead drug Ampligen can decrease the infectious viral yield of...

2 weeks ago
Deep dive

FSD Pharma throws resources behind legacy anti-inflammatory drug as...

The company plans a Phase 2 study of FSD201 in more than 300 COVID-19 patients in October this year

2 weeks, 1 day ago

Antibe’s breakthrough osteoarthritis pain relief drug in the spotlight on...

The company’s lead drug otenaproxesul, formerly known as ATB-346, could be a home run if it...

2 weeks, 1 day ago

Canntab Therapeutics received purchase order from Australia while also...

Canntab Therapeutics (CSE: PILL-OTCQB: CTABF) CFO Richard Goldstein joined Steve Darling from Proactive Vancouver with news the company has announced the launch of its suite of hard pill cannabinoid formulations in Australia with its partner CANN Global Ltd. Goldstein takes Proactive through...

12 hours, 48 minutes ago

Join Proactive

Get ahead of the curve

First with the equities news

Get our market previews and stories before the main networks.

Widest with the analysis

Not just the FTSE. Read about
opportunities from the whole
equities market.

Closest to the source

Hear directors at first-hand
or meet them in person at our events.

In at the start

Watch IPOs and access on the same terms as the institutions.